Insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations compared to stimulated growth hormone (GH) in the evaluation of children treated for malignancy

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 5, 1999, Pages 629-638

  Cicognani, Alessandro ^a   Cacciari, Emanuele ^a,c   Pession, Andrea ^a   Pasini, Andrea ^a   De Iasio, Rosaria ^b   Gennari, Monia ^a   Alvisi, Patrizia ^a   Pirazzoli, Piero ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Clinica Pediatrica I   (Italy)

Author keywords

IGF I, IGFBP 3, GH, malignancies, radiotherapy, total body irradiation, bone marrow transplantation, growth

Indexed keywords

ARGININE; GROWTH HORMONE; LEVODOPA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY GROWTH; BODY HEIGHT; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEAD TUMOR; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; SCREENING TEST; WHOLE BODY RADIATION;

EID: 0032864742     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.5.629     Document Type: Article

References (34)

1. Sklar C, Mertens A, Walter A, Mitchell D, Nesbit M, O'Leary M, Hutchinson R, Meadows A, Robinson L. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 1993; 123: 59-64.
2. Cicognani A, Cacciari E, Rosito P, Mancini AF, Carlà G, Mandini M, Paolucci G. Longitudinal growth and final height in long-term survivors of childhood leukemia. Eur J Pediatr 1994; 153: 726-730.
3. Clement-De Boers A, Oostdijk W, Van Weel-Spman MH, Van den Broeck J, Wit JM, Vossen JM. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996; 129: 544-550.
4. Shalet SM, Didi M, Ogilvy-Stuart AL, Schluga J, Donaldson MDC. Growth and endocrine function after bone marrow transplantation. Clin Endocrinol 1995; 42: 333-339.
5. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 1991; 118: 226-228.
6. Cicognani A, Cacciari E, Carlà G, Rosito P, Cau M, Mancini AF, Zucchini S, Vecchi V, Pirazzoli P, Paolucci G. Magnetic resonance imaging of the pituitary area in children treated for acute lymphoblastic leukemia with low-dose (18-Gy) cranial irradiation. Relationships to growth and growth hormone secretion. Am J Dis Child 1992; 146: 1343-1348.
7. Uruena M, Stanhope R, Chessels JM, Leiper AD. Impaired pubertal growth in acute lymphoblastic leukemia. Arch Dis Child 1991; 66: 1403-1407.
8. Juul A, Kastrup KW, Pedersen SA, Skakkebæ NE. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3. J Clin Endocrinol Metab 1997; 82: 1195-1201.
9. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993; 76: 1610-1616.
10. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993; 77: 1294-1299.
11. Adan L, Souberbielle J-C, Brauner R. Diagnostic markers of permanent idiopathic growth hormone deficiency. J Clin Endocrinol Metab 1994; 78: 353-358.
12. Ranke MB, Elmlinger M. Functional role of insulin-like growth factor binding proteins. Horm Res 1997; 48 (Suppl 4): 9-15.
13. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebæk NE. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995; 80: 2534-2542.
14. Blum WF, Ranke MB. Use of insulin-like growth factor binding protein-3 for the evaluation of growth disorders. Horm Res 1990; 33 (Suppl 4): 31-37.
15. Preece MA. Making a rational diagnosis of growth hormone deficiency. J Pediatr 1997; 131: S61-S64.
16. Rosenfeld RG. Biochemical diagnostic strategies in the evaluation of short stature: the diagnosis of insulin-like growth factor deficiency. Horm Res 1996; 46: 170-173.
17. Juul A, Skakkebæk NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum level of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 1997; 130: 197-204.
18. Philip M, Chalew SA, Kowarski AA, Stene MA. Plasma IGFBP-3 and its relationship with quantitative growth hormone secretion in short children. Clin Endocrinol 1993; 39: 427-432.
19. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity: British children, 1965. Part I. Arch Dis Child 1966; 41: 454-471.
20. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity: British children, 1965. Part II. Arch Dis Child 1966; 41: 613-635.
21. Rolland-Cachera MF, Cole TJ, Sempé M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991; 45: 13-21.
22. Cacciari E, Tassoni P, Cicognani A, Pirazzoli P, Salardi S, Balsamo A, Cassio A, Zucchini S, Colli C, Tassinari D, Tani G, Gualandi S. Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient. J Clin Endocrinol Metab 1994; 79: 1663-1669.
23. Nunez SB, Municchi G, Barnes KM, Rose SR. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children. A clinical research center study. J Clin Endocrinol Metab 1996; 81: 1927-1932.
24. Tillmann V, Buckler JMH, Kibirige MS, Price DA, Shalet SM, Wales JKH, Addison MG, Gill MS, Whatmore AJ, Clayton PE. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 531-535.
25. Adan L, Souberbielle J-C, Blanche S, Leverger G, Schaison G, Brauner R. Adult height after cranial irradiation with 24 Gy: factors and markers of height loss. Acta Paediatr 1996; 85: 1096-1101.
26. Brauner R, Adan L, Souberbielle J-C, Esperon H, Michon J, Devergie A, Gluckman E, Zucker JM. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplant-ation. J Pediatr 1997; 130: 785-792.
27. Cianfarani S, Boemi S, Spagnoli A, Cappa M, Argiró G, Vaccaro F, Manca Bitti ML, Boscherini B. Is IGF binding protein-3 assessment helpful for the diagnosis ofGH deficiency? Clin Endocrinol 1995; 43: 43-47.
28. Sklar C, Sarafoglou K, Whittam E. Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol (Copenh) 1993; 129: 511-515.
29. Nivot S, Benelli C, Clot JP, Saucet C, Adan L, Souberbielle J-C, Zucker JM, Rappaport R, Brauner R. Nonparallel changes of growth hormone (GH) and insulin-like growth factor-I, insulin-like growth factor binding protein-3, and GH-binding protein after craniospinal irradiation and chemotherapy. J Clin Endocrinol Metab 1994; 78: 597-601.
30. Rappaport R, Souberbielle JC, Benelli C. Growth hormone/insulin-like growth actor I axis in children treated for brain tumours: relationship to chemotherapy and nutrition. Acta Paediatr 1991; Suppl 411: 37-39.
31. Möller S, Jull A, Becker U, Flyvbjerg A, Skakkebæk NE, Henriksen JH. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 1995; 80: 1148-1157.
32. Miell JP, Zini JD, Portioli I, Valcavi R. Reversible effects of cessation and recomencements of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy. J Clin Endocrinol Metab 1994; 79: 1507-1512.
33. Cacciari E, Tassoni P, Parisi G, Pirazzoli P, Zucchini S, Mandini M, Cicognani A, Balsamo A. Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient. J Clin Endocrinol Metab 1992; 74: 1284-1289.
34. Shalet SM, Price DA, Beardwell CG, Morris Jones PH, Pearson D. Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia. J Pediatr 1979; 94: 719-722.